Stock screener

QDEL

Conviction 53HealthcareScan · Mon, Aug 10, 2026
Bullish engulfing
QDEL$13.76+12.01%
ResistanceSupportVol 14
63 bars
Vol MA14 1.91M
May 11May 28Jun 16Jul 6Jul 23Aug 10
QuidelOrtho CorpIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.quidelortho.com
Price13.76
Change+12.01%
Gap-0.98%
Rel volume5.33×
Avg volume1.66M
Avg $ vol25.88M
SMA 2016.62
SMA 5015.65
SMA 20020.49
Price vs 50-12.09%
Price vs 200-32.84%
MA stackbearish
50/200 cross
Supertrenddown · 16.73
RSI (14)39
MACD hist-0.48
MACD cross
Stoch %K / %D35 / 27
ADX (14)21
+DI / −DI18 / 37
RSI divergence
MACD divergence
ATR %+10.22%
ADR %6.59%
52w high35.38
52w low9.96
From 52w high-61.11%
Above 52w low+38.15%
New 52w highNo
SqueezeOff
Bollinger width32.86%
%B-0.02
Donchian pos30.84%
Donchian high19.03
Donchian low11.41
AVWAP (52w high)16.11
vs AVWAP high-14.58%
AVWAP (52w low)14.35
vs AVWAP low-4.09%
OBV trendFlat
Chaikin MF (20)0.13
Today vs 20d5.33×
Avg vol (14d)1.91M
Avg vol (20d)1.66M
Avg $ vol (20d)25.88M
Market cap943.6M
RS 3m (vs SPY)+8.37%
RS 6m (vs SPY)-71.29%
RS line new highNo
Trend template2/8
Technical rank6.6
1 week-22.30%
1 month-24.69%
3 months+27.41%
6 months-52.71%
1 year-43.61%
YTD-52.19%
P/E-0.83
P/B0.53
P/S0.35
P/FCF-11.37
EPS-16.69
Div yield
ROE-63.77%
ROA-19.80%
Debt/Eq1.72
Current1.39
EV/EBITDA-8.12
Gross margin
Net margin-41.45%
Rev growth-1.89%
EPS growth44.84%
Price target15.00
Target upside9.01%
Analyst ratingSell
Institutional135.18%
Ent. value3.87B
Revenue630.9M
Net income-92.9M
Gross profit
Free cash flow-83M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out68.19M
Employees6.5K
ListedTue, Aug 4, 1981
Free float67.45M
Float %99.1%
Short interest11.8M
Days to cover9.8d
Short volume55.0%
Squeeze score85 / 100
Next earnings
EPS forecast
Last EPS vs est$0.13 vs −$0.04
Last surprise+425.0% beat
Setup gradeC
Conviction53 / 100
Pattern quality
Tech rank6.6 / 100
Group rank86 / 100 · Leading
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBullish engulfing
News sentiment

Financials as of Sun, Jun 28, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QDEL

All disclosures →
No recent disclosed trades by Congress in QDEL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QDEL · 10 buys

InsiderSideShares
Young Micah W
Chief Financial Officer · Restricted Stock Units · 2026-07-15
Grant356.56K
Michael Edward L.
Director · Restricted Stock Units (Equity Grant) · 2026-06-25
Grant15.53K
Huennekens R Scott
Director · Restricted Stock Units (Equity Grant) · 2026-06-25
Grant15.53K
BUECHLER KENNETH F
Director · Restricted Stock Units (Equity Grant) · 2026-06-25
Grant15.53K
BUECHLER KENNETH F
Director · Restricted Stock Units (Converted) · 2026-06-25
Grant12.2K
BUECHLER KENNETH F
Director · Restricted Stock Units (Premium) · 2026-06-25
Grant3.66K
Chiminski John R
Director · Restricted Stock Units (Equity Grant) · 2026-06-25
Grant15.53K
Chiminski John R
Director · Restricted Stock Units (Converted) · 2026-06-25
Grant5.55K
Chiminski John R
Director · Restricted Stock Units (Premium) · 2026-06-25
Grant1.11K
POLAN MARY LAKE PH D
Director · Restricted Stock Units (Equity Grant) · 2026-06-25
Grant15.53K

SEC filings

EDGAR filings in QDEL · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.